Protective Effects of Ferulic Acid in Alcohol Withdrawal Induced Anxiety and Depression in Mice
DOI:
https://doi.org/10.18034/mjmbr.v4i1.427Keywords:
Anxiolytic, Antidepressant, Ethanol withdrawal symptoms, Ferulic acidAbstract
Background: Anxiety and depression are the most important troubling symptoms of continuous alcoholism. Objective: The present study was designed to examine the protective effects of ferulic acid in alcohol withdrawal-induced anxiety and depression in experimental mice.
Methods: Male albino mice were divided into different groups. They were received 10% ethanol (2 g/kg; p.o.) twice on the first day and once on successive days for total six days, after 24 hrs. Withdrawal symptoms were observed using the different model for anxiety and depression such as elevated plus maze, open field test, hole board test, marble burying test and tail suspension test. Ferulic acid was tested as 10 and 20 mg/ kg, orally.
Results: Treatment with ferulic acid (10 and 20 mg/kg, p.o) showed significant reduction of alcohol withdrawal syndromes in different models. Taken together our result showed a protective effect in alcohol withdrawal anxiety and depression as tested in well-established animal models.
Conclusion: The present study showed that ferulic acid dose-dependently prevents alcohol withdrawal-induced anxiety and depression in mice.
Downloads
References
Bhattacharya S K, Bhattacharya A, Sairam K, Ghosal S, (2002) Anxiolytic-antidepressant activity of Withania Somnifera glycowithanolides: an experimental study, Phytomedicine, 7, 463-469.
Broekkamp C L, Rijk H W, Joly D, Lloyd K L, (1986). Major tranquillizers can be distinguished from minor tranquillizers on the basis of effects on marble burying in mice, European Journal of Pharmacology, 126, 223-229.
Crawley J, Goodwin K K, (1980). Preliminary report of a simple animal behaviour model for the anxiolytic effect of benzodiazepines, Pharmacology Biochemical Behavior, 13, 167-170.
Di Chiara, Imperato A, (1988). Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats, Neurobiology, 85, 5274-5278.
Gershenfeld H K, Liu X, (2001). Genetic differences in tail suspension test and its relationship to Imipramine response among inbred strains of mice. Biology of Psychiatry, 49, 575-581.
Hata T, Hiroyunki N, Itoh E, Funakamo Y, (2000). Anxiety-Like Behavior in Elevated Plus-Maze Tests in Repeatedly Cold-Stressed Mice, Japanese Journal of Pharmacology, 85, 89-196.
Heilig M, Egli M, Crabbe J C, Beacker H C, (2010). Acute withdrawal protected abstinence and negative effect in alcoholism: are they linked? Addiction Biology, 15, 169-184.
Hundson E A, Dinh P A, Kokubun T, Simmonds M S, Gescher A C, (2002). Characterization of potentially chemopreventive phenols in extracts of brown rice that inhibit the growth of human breast and colon cancer cells, Cancer Epidemiology Biomarkers, 9, 1163-1170.
Jung E H, Kim S R, Hwang I K, (2007). Hypoglycemic effects of a phenolic acid fraction of rice bran and ferulic acid in C57bl/KsJ-db/db mice, Journal of Agriculture Food and Chemical, 55, 9800-9804
Kalant H, (1993). Research and tolerance: What can we learn from history? Alcoholism: Clinical Experimental Research, 22, 67-74.
Kliethermes C L, (2005). Anxiety-like behaviors following chronic ethanol exposure, Neuroscience Biobehavioral Research, 28, 837.
Kulkarni S K, (2008). Effect of different novel class of drugs as antianxiety activity, Indian Journal of Experimental Biology, 46, 633-638.
Landolt H P, Gillin J C, (2001). Sleep abnormalities during abstinence in alcohol-dependent patients. Etiology and Management of CNS drugs, 15,413-425.
Lister R G, (1987). The use of a plus maze to measure anxiety in the mouse. Psychopharmacology (Berlin) 92,180-185.
Njung’e K and Handley S L, (1991). British Journal of Pharmacology, 104, 105.
Pellow S and File S E, (1986). Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus maze: A novel text of anxiety in the rat, Pharmacology Biochemistry Behavior, 24,525.
Robert A J and Koob G F, (1997). The Neurobiology of Addiction: An Overview, Alcohol Health and Research World, 21(2), 101-106.
Sellers E M, Higgins G A, Sobel M R, (1992). 5-HT and alcohol abuse. Trends in Pharmacological Science, 13, 69-75.
Snell L D, Nunley K, Lickteig R, Browning M, Hoffman P, (1996). Regional and subunit specific changes in NMDA receptor mRNA and immunoreactivity in mouse brain following chronic ethanol ingestion, Molecular Brain Research, 40, 71-78.
Steru L, Chermat R, Thierry B, Simon P,(1985). The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology, 85, 367-370.
Westerberg H G, (1999). Facing the challenge of social anxiety disorder, Neuropsychopharmacology, 9(3), 93-99.
Ying-jin Zhang, Xi Huang, Yang Wang, Ying Xie, (2011). Ferulic acid-induced anti-depression and prokinetics similar to Chaihi-Shugan-San, polypharmacology Brain Research Bulletin, 86, 222-228.
Yoon B H, Chori J W, Jung J W, Shin J S, Hyeon, Ryu J H, (2005). Anxiolytic effect of phenylpropanoid compounds using the Elevated plus-maze in mice, Life Science, 49 (5), 437-442.
-- 0 --
